AE Wealth Management LLC Purchases Shares of 5,859 Hims & Hers Health, Inc. $HIMS

AE Wealth Management LLC purchased a new stake in Hims & Hers Health, Inc. (NYSE:HIMS) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 5,859 shares of the company’s stock, valued at approximately $292,000.

A number of other institutional investors also recently made changes to their positions in HIMS. Quaker Wealth Management LLC bought a new stake in shares of Hims & Hers Health during the 2nd quarter valued at $29,000. Bessemer Group Inc. raised its stake in Hims & Hers Health by 105.8% in the second quarter. Bessemer Group Inc. now owns 607 shares of the company’s stock valued at $30,000 after purchasing an additional 312 shares in the last quarter. Geneos Wealth Management Inc. bought a new stake in Hims & Hers Health during the first quarter worth about $30,000. BI Asset Management Fondsmaeglerselskab A S bought a new stake in Hims & Hers Health during the first quarter worth about $41,000. Finally, Larson Financial Group LLC grew its stake in Hims & Hers Health by 47.7% during the first quarter. Larson Financial Group LLC now owns 1,419 shares of the company’s stock worth $42,000 after buying an additional 458 shares in the last quarter. Institutional investors own 63.52% of the company’s stock.

Analysts Set New Price Targets

Several analysts recently weighed in on HIMS shares. Zacks Research downgraded Hims & Hers Health from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, August 19th. UBS Group set a $32.00 price target on shares of Hims & Hers Health in a research note on Tuesday, November 4th. KeyCorp started coverage on shares of Hims & Hers Health in a report on Tuesday, October 21st. They set a “sector weight” rating on the stock. Canaccord Genuity Group reissued a “buy” rating and issued a $68.00 price objective on shares of Hims & Hers Health in a research note on Friday, September 12th. Finally, Wall Street Zen lowered shares of Hims & Hers Health from a “hold” rating to a “sell” rating in a research report on Saturday, November 8th. Two equities research analysts have rated the stock with a Buy rating, ten have given a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat, Hims & Hers Health has an average rating of “Reduce” and a consensus target price of $45.27.

Insider Activity

In other news, insider Michael Chi sold 900 shares of the business’s stock in a transaction on Friday, October 10th. The shares were sold at an average price of $58.25, for a total transaction of $52,425.00. Following the sale, the insider owned 291,439 shares in the company, valued at approximately $16,976,321.75. The trade was a 0.31% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Soleil Boughton sold 2,637 shares of the firm’s stock in a transaction that occurred on Monday, November 10th. The shares were sold at an average price of $42.53, for a total value of $112,151.61. Following the transaction, the insider directly owned 155,856 shares of the company’s stock, valued at approximately $6,628,555.68. This trade represents a 1.66% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 584,209 shares of company stock valued at $31,837,916. Corporate insiders own 17.71% of the company’s stock.

Hims & Hers Health Stock Performance

HIMS stock opened at $37.09 on Monday. The company has a quick ratio of 1.64, a current ratio of 1.88 and a debt-to-equity ratio of 1.67. The firm has a market cap of $8.44 billion, a PE ratio of 68.68, a P/E/G ratio of 7.36 and a beta of 2.20. The business has a 50 day moving average of $50.63 and a 200-day moving average of $51.46. Hims & Hers Health, Inc. has a 12-month low of $19.15 and a 12-month high of $72.98.

Hims & Hers Health (NYSE:HIMS) last issued its earnings results on Monday, November 3rd. The company reported $0.06 earnings per share for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.03). Hims & Hers Health had a return on equity of 24.67% and a net margin of 6.05%.The business had revenue of $598.98 million for the quarter, compared to the consensus estimate of $578.99 million. During the same quarter in the prior year, the business earned $0.32 EPS. Hims & Hers Health’s revenue for the quarter was up 49.2% compared to the same quarter last year. Hims & Hers Health has set its FY 2025 guidance at EPS. Q4 2025 guidance at EPS. As a group, sell-side analysts expect that Hims & Hers Health, Inc. will post 0.29 earnings per share for the current year.

Hims & Hers Health Company Profile

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.